10-Year Statute of Repose Bars Reglan/Metoclopramide Action, Neb. Federal Judge Rules
August 23, 2016
DOCUMENTS
- Order
OMAHA, Neb. — Nebraska’s 10-year statute of repose bars a product liability lawsuit filed against the makers of Reglan and its generic equivalent because the record lacks evidence that the drug makers concealed research linking the drugs to a movement disorder, a federal judge has ruled.
On Aug. 19, Chief Judge Laurie S. Camp of the U.S. District Court for the District of Nebraska further held that the passage of the 10-year period following the plaintiff’s first Reglan/metoclopramide prescription in 1988 vested the defendants with a substantive right under § 25-224(2) as it existed prior to 2001, and as such, …
FIRM NAMES
- Irwin Fritchie Urquhart & Moore
- Kaye Scholer
- Kutak Rock
- Mayer Brown
- Medical Legal Consultants
- Rembolt Ludtke
- Shively Lannin
- Watkins Eager
UPCOMING CONFERENCES
HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates
May 29, 2024 - Salt Lake City, UT
The Grand America Hotel
HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone
June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo